Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2131-2139

  Wang, Sheng ^a   Mo, Xiu M ^b   Jiang, Bo J ^a   Gao, Cheng J ^a   Wang, Hong S ^b   Zhuang, Yu G ^a   Qiu, Li J ^b  

^a TONGJI UNIVERSITY   (China)

^b DONGHUA UNIVERSITY   (China)

Author keywords

Electrospinning; Endothelialization; Heparin; Patency rate; Vascular graft

Indexed keywords

HEPARIN; MOLECULAR SCAFFOLD; NANOFIBER; POLYLACTIDE CO EPSILON CAPROLACTONE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL SHUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOG; ELECTROSPINNING; ENDOTHELIUM CELL; FEMORAL ARTERY; GRAFT PATENCY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NANOFABRICATION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TENSILE STRENGTH;

ELECTROSPINNING; ENDOTHELIALIZATION; HEPARIN; PATENCY RATE; VASCULAR GRAFT;

ANIMALS; BLOOD VESSEL PROSTHESIS; CELL SURVIVAL; DOGS; ELECTROCHEMICAL TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; HEPARIN; NANOCOMPOSITES; NANOFIBERS; NANOTECHNOLOGY; POLYESTERS; TISSUE SCAFFOLDS; VASCULAR PATENCY;

EID: 84878798957     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44956     Document Type: Article

References (28)

1. McBane JE, Sharifpoor S, Labow RS, Ruel M, Suuronen EJ, Santerre JP. Tissue engineering a small diameter vessel substitute: engineering constructs with select biomaterials and cells. Curr Vasc Pharmacol. 2012; 10(3):347-360.
2. Peck M, Gebhart D, Dusserre N, McAllister TN, L'Heureux N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs. 2012;195(1-2):144-158.
3. Li S, Henry JJ. Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng. 2011;13:451-475.
4. Chlupác J, Filová E, Bacáková L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res. 2009;58 Suppl 2:S119-S139.
5. Song Y, Feijen J, Grijpma DW, Poot AA. Tissue engineering of small-diameter vascular grafts: a literature review. Clin Hemorheol Microcirc. 2011;49(1-4):357-374.
6. Khan OF, Sefton MV. Endothelialized biomaterials for tissue engineering applications in vivo. Trends Biotechnol. 2011;29(8):379-387.
7. Hung HS, Chen HC, Tsai CH, Lin SZ. Novel approach by nanobiomaterials in vascular tissue engineering. Cell Transplant. 2011;20(1): 63-70.
8. Villalona GA, Udelsman B, Duncan DR, et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev. 2010;16(3): 341-350.
9. Krawiec JT, Vorp DA. Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials. 2012;33(12):3388-3400.
10. Gray E, Hogwood J, Mulloy B. The anticoagulant and antithrombotic mechanisms of heparin. Handb Exp Pharmacol. 2012;(207):43-61.
11. Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J Vasc Surg. 2009;49(5):1210-1216.
12. Haude M, Konorza TF, Kalnins U, et al; Heparin-COAted STents in small coronary arteries Trial Investigators. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation. 2003;107(9):1265-1270.
13. Rathore A, Cleary M, Naito Y, Rocco K, Breuer C. Development of tissue engineered vascular grafts and application of nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(3):257-272.
14. Spadaccio C, Chello M, Trombetta M, Rainer A, Toyoda Y, Genovese JA. Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med. 2009;13(3):422-439.
15. Mo XM, Xu CY, Kotaki M, Ramakrishna S. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials. 2004;25(10):1883-1890.
16. Zhang K, Wang H, Huang C, Su Y, Mo X, Ikada Y. Fabrication of silk fibroin blended P(LLA-CL) nanofibrous scaffolds for tissue engineering. J Biomed Mater Res A. 2010;93(3):984-993.
17. Su Y, Li X, Liu Y, Su Q, Qiang ML, Mo X. Encapsulation and controlled release of heparin from electrospun poly(L-Lactide-co-epsilon-Caprolactone) nanofibers. J Biomater Sci Polym Ed. 2011;22: 165-177.
18. Hiep NT, Lee BT. Electro-spinning of PLGA/PCL blends for tissue engineering and their biocompatibility. J Mater Sci Mater Med. 2010;21(6):1969-1978.
19. Lu H, Feng Z, Gu Z, Liu C. Growth of outgrowth endothelial cells on aligned PLLA nanofibrous scaffolds. J Mater Sci Mater Med. 2009;20(9):1937-1944.
20. Saik JE, McHale MK, West JL. Biofunctional materials for directing vascular development. Curr Vasc Pharmacol. 2012;10(3):331-341.
21. Naito Y, Shinoka T, Duncan D, et al. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev. 2011;63(4-5):312-323.
22. Gui L, Zhao L, Spencer RW, et al. Development of novel biodegradable polymer scaffolds for vascular tissue engineering. Tissue Eng Part A. 2011;17(9-10):1191-1200.
23. Byrom MJ, Bannon PG, White GH, Ng MK. Animal models for the assessment of novel vascular conduits. J Vasc Surg. 2010;52(1): 176-195.
24. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs. 2002;26(4):307-320.
25. Dahl SL, Blum JL, Niklason LE. Bioengineered vascular grafts: can we make them off-the-shelf? Trends Cardiovasc Med. 2011;21(3): 83-89.
26. Tatterton M, Wilshaw SP, Ingham E, Homer-Vanniasinkam S. The use of antithrombotic therapies in reducing synthetic small-diameter vascular graft thrombosis. Vasc Endovascular Surg. 2012;46(3): 212-222.
27. Bosiers M, Deloose K, Verbist J, et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg. 2006;43(2):313-318; discussion 318-319.
28. Scharn DM, Daamen WF, van Kuppevelt TH, van der Vliet JA. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design. Eur J Vasc Endovasc Surg. 2012;43(1):66-72.